Activity

Besides, the as-assembled symmetric solid-state supercapacitor exhibits an energy density of 29.7 Wh L-1 and excellent mechanical flexibility. We believe that the present nanostructure design, decorating NPs within a two-dimensional metallic network, has general applicability and could be used to fabricate highly efficient composites for advanced energy storage devices.Cu-based p-type semiconducting oxides have been sought for water-reduction photocathodes to enhance the energy-conversion efficiency in photoelectrochemical cells. CuBi2O4 has recently attracted notable attention as a new family of p-type oxides, based on its adequate band gap. Although the identification of a major defect structure should be the first step toward understanding the electronic conduction behavior, no direct experimental analysis has been carried out yet. Using atomic-scale scanning transmission electron microscopy together with chemical probing, we identify a substantial amount of BiCu-CuBi antisite intermixing as a major point-defect type. Our density functional theory calculations also show that antisite BiCu can seriously hinder the hole-polaron hopping between Cu, in agreement with lower conductivity and a larger thermal activation barrier under a higher degree of intermixing. GSK923295 cell line of the direct identification of point defects for a better understanding of electronic properties in complex oxides.ConspectusMetal chalcogenide supertetrahedral clusters (MCSCs) bear the closest structural resemblance to II-VI or I-III-VI semiconductor nanocrystals and can be considered as well-defined ultrasmall “quantum dots” (QDs). Compared to traditional colloidal QDs that are typically associated with size dispersity, irregular surface atomic structures, poorly defined core-ligand interfaces, and random defect/dopant sites, the nano- or subnano-sized MCSCs feature precise structural properties such as atomically uniform size, precise structure, and ordered dopant distribution, all of which offer ample opportunities for a broad and in-depth understanding of the correlation between the precise local structure and site- or size-dependent properties, which are critical to the exploitation of their functional applications. Our previous Account in 2005 provided a narrative on the efforts to expand the structural diversity of open-framework materials using different-sized and compositionally tunable clusters as building blotional expansion via host-guest chemistry, and dispersed cluster-based composite materials with synergy from functional multimetallic components. All these advances show that MCSCs with well-defined structures and atomically precise dopant/defect sites are powerful model systems for establishing the precise structure-composition-property correlation and understanding the photophysical dynamic behaviors, both of which are difficult or impossible to achieve in the traditional QD system. Perspectives on their potential applications are presented in terms of the amorphous assemblies of monodispersed MCSCs, MCSC-based two-dimensional layered materials, and optical/electronic devices.Liposomes are small spherical vesicles composed mainly of phospholipids and cholesterol. Over the years, a number of liposomal formulations have shown clinical promise, but the use of liposomes in oral drug delivery is limited. This is partly due to the vulnerability of conventional liposomes to the detrimental effect of gastrointestinal destabilizing factors and also to the poor efficiency in intestinal absorption of liposomes. Some of these issues can be ameliorated using the layer-by-layer (LbL) assembly technology, which has been widely applied to modify the surface of various nanoparticulate systems. Discussions about LbL functionalization of liposomes as oral drug carriers, however, are scant in the literature. To fill this gap, this review presents an overview of the roles of LbL functionalization in the development of liposomes, followed by a discussion about major principles of molecular design and engineering of LbL-functionalized liposomes for oral drug delivery. Regarding the versatility offered by LbL assembly, it is anticipated that LbL-functionalized liposomes may emerge as one of the important carriers for oral drug administration in the future.The determination of T4 polynucleotide kinase (PNK) activity and the screening of PNK inhibitors are critical to disease diagnosis and drug discovery. #link# Numerous electrochemical strategies have been developed for the sensitive measurement of PNK activity and inhibition. However, they often suffer from additional labels and multiple steps of the detection process for the electrochemical readout. Herein, we have demonstrated an electrochemical DNA (E-DNA) sensor for the one-step detection of PNK with “signal-on” readout with no need for additional labels. In our design, the highly switchable double-stranded DNA (dsDNA) probes are immobilized on the gold nanoparticle-decorated molybdenum disulfide nanomaterial (MoS2-AuNPs), which possesses large surface area and high conductivity for elevating the signal gain in the PNK detection. This signal-on E-DNA sensor integrated with MoS2-AuNPs exhibits a much higher sensitivity than that without MoS2-AuNPs, showing a detection limit of 2.18 × 10-4 U/mL. Furthermore, this assay shows high selectivity, with the ability to discriminate PNK from other enzymes and proteins, and can be utilized to screen inhibitors. The proposed sensor is easy to operate with one-step readout and robust for PNK detection in the biological matrix and shows great potential for point-of-care in clinical diagnostics and drug screening.Immunotherapy has attracted significant interest because of its tremendous potential in cancer therapy. The recent advances in the identification of cancer-associated neoantigens, chimeric antigen receptor (CAR) T-cell and immune checkpoint blockade (ICB), have revolutionized the field of cancer immunotherapy. Cancer immunotherapeutic agents typically exhibit strong immune activation or inhibition activity, thereby inducing robust biological effect even when administered at a small dosage. However, in most cases, cancer immunotherapeutic targets are not cancer specific. Some of them are also expressed in nonmalignant normal tissues and the undesired release of the cancer immunotherapeutic agents into these normal tissues may lead to severe side effects. Thus, the on-demand release of the cancer immunotherapeutic agents into the target site is critical to achieving efficient antitumor immune responses while minimizing the side effects.In this Account, we introduce the recent progress of our group and others on the development of stimuli-responsive platforms for cancer immunotherapy.